Home › Funds › BENEDICT FINANCIAL ADVISORS INC › ABT

BENEDICT FINANCIAL ADVISORS INC position in ABT

ABBOTT LABORATORIES · Health Care

BENEDICT FINANCIAL ADVISORS INC reported holding 34,869 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$3.4M, representing 0.68% of its reported portfolio and ranking #50 among its reported holdings. BENEDICT FINANCIAL ADVISORS INC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)34.87K sh
Reported value held$3.45M
Portfolio Weight0.68%
First reportedQ3 2023
Last changeAdd
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How BENEDICT FINANCIAL ADVISORS INC's ABT position evolved

BENEDICT FINANCIAL ADVISORS INC first disclosed a stake in ABT in Q3 2023 at 34,998 shares (US$3.4M). The position peaked in Q2 2025 at 32,994 shares, worth US$4.5M. Across 13 filings, BENEDICT FINANCIAL ADVISORS INC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 34,869 shares valued at US$3.4M — an increase of 376 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 35.00K $3.39M New
Q4 2023 34.52K $3.80M Reduce
Q1 2024 34.23K $3.89M Reduce
Q2 2024 34.08K $3.54M Hold
Q3 2024 33.64K $3.83M Reduce
Q4 2024 33.49K $3.79M Hold
Q1 2025 33.07K $4.39M Reduce
Q2 2025 32.99K $4.49M Hold
Q3 2025 32.46K $4.35M Reduce
Q4 2025 32.33K $4.05M Hold
Q1 2026 32.70K $3.36M Add
Q2 2026 34.49K $3.13M Add
Q3 2026 34.87K $3.45M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has BENEDICT FINANCIAL ADVISORS INC held ABT?

BENEDICT FINANCIAL ADVISORS INC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BENEDICT FINANCIAL ADVISORS INC's current position in ABT?

As of Q3 2026, BENEDICT FINANCIAL ADVISORS INC holds 34.87K shares of ABT (ABBOTT LABORATORIES), valued at $3.45M, representing 0.68% of its reported portfolio and ranking #50.

Has BENEDICT FINANCIAL ADVISORS INC been buying or selling ABT?

In the latest 13F filing (Q3 2026), BENEDICT FINANCIAL ADVISORS INC increased its position in ABT. The position peaked in Q2 2025 at 32.99K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.